Laboratory for immunogenetics (HLA laboratory)

Request forms and consent form

General notes:

• Requirement information checklist

HLA diagnostics in solid organ transplantation:

• Antibody diagnostics in solid organ transplantation
• Serological crossmatch in solid organ transplantation
• Typing in solid organ transplantation

HLA diagnostics in stem cell transplantation:

• HLA diagnostics in stem cell transplantation
• Chimerism analysis in stem cell transplantation

HLA diagnostics in disease associations / pharmacogenetics:

• Disease associations / pharmacogenetics
• Declaration of content according to GenDG

For external senders, the request (antibody diagnostics, crossmatch, HLA typing) is only valid in conjunction with a fully completed "laboratory bill 10" for persons with statutory health insurance.

Note on the Gene Diagnostics Act (GenDG)

In the opinion of the Board of the German Society for Immunogenetics (DGI), HLA examinations with the aim of determining compatibility do not fulfill the criteria of a diagnostic genetic examination according to § 3 GenDG and are therefore not subject to the regulations of this law. A corresponding declaration of consent can, of course, nevertheless also be sent for immunogenetic examinations as part of the compatibility determination.

Comment on the GenDG

Note on postal dispatch
The provision of packaging material or reimbursement of postage costs cannot be made by our laboratory as part of the Universitätsklinikum. When shipping samples, the valid regulations for the transport of hazardous substances and objects must be observed.

Regulations for mailing

Note on incurred costs

The costs for the examniations carried out by the Laboratory for Immunogenetics are charged in accordance with the EBM (for patients with statutory health insurance) or the GOÄ (for privately insured patients), in line with the guidelines of the professional association. If examinations are performed as part of internal requests, billing is carried out via internal cost allocation (further information can be found on the intranet).

Note on residual risk

Laboratory results can be influenced by many factors – not only by diseases, but also by medications, therapeutic measures and errors during sample collection, transport, or storage. Organizational risks, such as sample mix-ups, also play a role. Due to mandatory confirmatory typing prior to transplantation, the risk of incorrect typing is extremely low. Nevertheless, despite high quality standards, incorrect or delayed results cannot be completely ruled out. Through quality assurance measures, controls, and and close communication between the submitting institution and the laboratory, these risks are significantly reduced; however, a residual risk remains.